Christine Fox

Insider Reports History

Location
C/O Teva, 5 Basel Street, P.O. Box 3190, Petach Tikva, Israel
Signature
/s/ Dov Bergwerk as attorney-in-fact for Christine Fox
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Fox:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD EVP, Head of U.S. Commercial Ordinary Shares 28.4K $713K $25.11 Nov 14, 2025 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD EVP, Head of U.S. Commercial Restricted Share Units 71.3K Mar 5, 2025 Direct

Insider Reports Filed by Christine Fox

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Nov 14, 2025 1 -$753K 4 Nov 18, 2025 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 5, 2025 1 $0 4 Mar 7, 2025 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2025 4 -$97.6K 4 Mar 6, 2025 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Nov 20, 2024 3 -$327K 4 Nov 21, 2024 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2024 1 $0 4 Mar 5, 2024 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Nov 20, 2023 1 $0 4 Nov 22, 2023 EVP, Head of U.S. Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Nov 20, 2023 0 $0 3 Nov 22, 2023 EVP, Head of U.S. Commercial